Treatment Options for Necrotising Fasciitis

Necrotising fasciitis (NF) is a serious medical emergency that requires immediate surgical intervention. Antimicrobial therapy and support alone have shown to have a mortality rate of almost 100%. The primary goal of surgical intervention is to remove all necrotic tissue until healthy, viable tissue is reached. This can be done through surgical debridement in theatre or bedside wound debridement by a plastic surgeon in an aseptic environment.

Hyperbaric oxygen (HBO) treatment is believed to increase the bactericidal effects of neutrophils and can be useful in treating synergistic infections. However, access to HBO units with appropriate staffing and chambers large enough for intensive care patients is limited.

IV immunoglobulin (IVIG) has shown potential benefits in group A streptococcal (GAS) infections, but further studies are needed to determine its exact benefits in NF.

While X-ray, MRI, and CT scans can aid in the diagnosis of NF, surgical treatment should never be delayed for these tests. Immediate surgical intervention is crucial in treating this life-threatening condition.

Completing the Death Certificate: Guidelines for Medical Practitioners

When a patient passes away, it is the responsibility of the attending medical practitioner to issue the certification of death. However, there may be some confusion regarding who is eligible to complete the death certificate and the accompanying forms. Here are some guidelines to help medical practitioners navigate this process.

Requirements for Completing Form Cremation 4
If the deceased is to be cremated, a separate form (Form Cremation 4) must be completed by a registered medical practitioner. To be eligible to sign this form, the practitioner must:

– Be registered with a licence to practise from the General Medical Council (GMC)
– Have treated the deceased during their last illness and seen them within 14 days of death
– Have cared for the patient before death or been present at the time of death
– Have examined the body after death

Referral to the Coroner
If the death was sudden or unexpected, or if the cause of death is unknown, the practitioner must refer the case to the coroner. Other indications for referral include suspicious or violent deaths, deaths due to accidents or neglect, deaths related to prior employment or abortion, deaths during police custody, and suicides.

Completing the Death Certificate
The attending medical practitioner is responsible for completing the death certificate. There is no clear legal definition of attended, but it generally refers to a doctor who has cared for the patient during the illness that led to death and is familiar with their medical history, investigations, and treatment. The certifying doctor should also have access to relevant medical records and investigation results.

Navigating the Process of Completing Death Certificates for Medical Practitioners

As a medical practitioner, it is important to understand the guidelines for completing death certificates and accompanying forms. This includes eligibility requirements for signing Form Cremation 4, indications for referral to the coroner, and guidelines for completing the death certificate itself. By following these guidelines, practitioners can ensure that they are fulfilling their statutory duty and providing accurate information for the deceased’s family and loved ones.

Differential diagnosis of calcified lymph nodes and upper lobe fibrosis in a patient with rheumatoid arthritis

A patient with rheumatoid arthritis presents with calcified lymph nodes and upper lobe fibrosis on a chest X-ray. Several possible causes need to be considered, including active pulmonary tuberculosis, lymphoma, rheumatoid lung disease, bronchial carcinoma, and invasive aspergillosis. While anti-TNF antibody medication for rheumatoid arthritis may increase the risk of tuberculosis and aspergillosis, it is important to rule out other potential etiologies based on clinical examination, imaging studies, and laboratory tests. The presence of soft, fluffy, and ill-defined lesions on chest X-ray may suggest active tuberculosis, while the absence of upper lobe fibrosis may argue against lymphoma or radiotherapy-induced fibrosis. Pulmonary nodules and lung fibrosis at the lung bases are more typical of rheumatoid lung disease, but calcified nodes with upper lobe fibrosis are unusual. Bronchial carcinoma may be a concern given the patient’s age and smoking history, but typically lymph nodes are not calcified. Invasive aspergillosis is more likely in immunosuppressed patients and can be detected by a CT scan and a serum galactomannan test. A comprehensive differential diagnosis can guide further evaluation and management of this complex case.

Possible Causes of Hirsutism in Women: A Differential Diagnosis

Hirsutism, the excessive growth of hair in women in a male pattern, can be caused by various underlying conditions. Here are some possible causes and their distinguishing features:

Molar Pregnancy: This condition is characterized by hypertension in the first trimester of pregnancy. Excessive stimulation of ovarian follicles by high levels of gonadotrophins or human chorionic gonadotrophin (hCG) can lead to the formation of multiple theca lutein cysts bilaterally.

Congenital Adrenal Hyperplasia: This disease, which is mostly found in women, can present with gradual onset of hirsutism without virilization. It is caused by a deficiency of 21-hydroxylase and is characterized by an elevated serum concentration of 17-hydroxyprogesterone.

Luteoma of Pregnancy: This benign, solid ovarian tumor develops during pregnancy and disappears after delivery. It may be associated with excess androgen production, leading to hirsutism and virilization.

Adrenal Tumor: Androgen-secreting adrenal tumors can cause rapid onset of severe hirsutism, with or without virilization. Amenorrhea is found in almost half of the patients, and testosterone and dihydrotestosterone sulfate concentrations are elevated.

Polycystic Ovary Syndrome: Women with this condition are at higher risk of developing pre-eclampsia. However, the development of hypertension in the first trimester of pregnancy makes it more likely that there is a molar pregnancy present, with theca lutein cysts seen on ultrasound.

In summary, hirsutism in women can be caused by various conditions, and a differential diagnosis is necessary to determine the underlying cause and appropriate treatment.

Ankylosing spondylitis (AS) patients can often find relief from their symptoms through the use of nonsteroidal anti-inflammatory drugs (NSAIDs) alone, according to the most recent guidelines from the European League Against Rheumatism (EULAR). In fact, continuous NSAID therapy is recommended for those with active and persistent symptoms, as it has been shown to slow the progression of the disease. While systemic glucocorticoids are not effective for managing AS, intra-articular steroid injections may be helpful for peripheral joint or enthesitis issues. Of traditional disease-modifying antirheumatic drugs (DMARDs), only sulphasalazine has been found to be effective for peripheral joint involvement, but it does not work for those with axial joint involvement. For those with insufficiently controlled symptoms, TNF-alpha inhibitors such as etanercept, infliximab, or adalimumab are recommended, without significant difference in efficacy between the three.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

Common Inducing Anaesthetic Agents and Their Uses

Propofol, etomidate, ketamine, midazolam, and thiopental are all commonly used inducing anaesthetic agents with varying properties and uses.

Propofol is the drug of choice for RSII procedures in normotensive individuals without obvious cardiovascular pathology. It has amnesic, anxiolytic, anticonvulsant, and muscle relaxant properties, but no analgesic effects.

Etomidate provides haemodynamic stability without histamine activity and minimal analgesic effects. It is used in RSI procedures in patients with raised intracranial pressure and cardiovascular conditions, often in combination with fentanyl.

Ketamine is a non-competitive glutamate N-methyl-D-aspartate (NMDA) receptor blocker that produces dissociative anaesthesia. It can be used for induction of anaesthesia in patients with hypotension, status asthmaticus, and shock, but is avoided in hypertensive patients due to relative contraindications.

Midazolam is a benzodiazepine with anticonvulsive, muscle relaxant, and anaesthetic actions. At higher doses or in combination with other opioids, it induces significant cardiovascular and respiratory depression.

Thiopental is administered intravenously as an inducing anaesthetic agent or as a short-acting anaesthetic. It is also used as an anticonvulsant agent and to decrease intracranial pressure in neurosurgical procedures.

Aspirin is recommended for all patients with ischaemic heart disease, unless there is a contraindication. However, the guidelines have been updated to suggest that patients with other types of cardiovascular disease, such as stroke and peripheral arterial disease, should be given clopidogrel as the first-line treatment.

The Mechanism and Guidelines for Aspirin Use in Cardiovascular Disease

Aspirin is a medication that works by blocking the action of cyclooxygenase-1 and 2, which are responsible for the synthesis of prostaglandin, prostacyclin, and thromboxane. By inhibiting the formation of thromboxane A2 in platelets, aspirin reduces their ability to aggregate, making it a widely used medication in cardiovascular disease. However, recent trials have cast doubt on the use of aspirin in primary prevention of cardiovascular disease, leading to changes in guidelines. Aspirin is now recommended as a first-line treatment for patients with ischaemic heart disease, but it should not be used in children under 16 due to the risk of Reye’s syndrome. The medication can also potentiate the effects of oral hypoglycaemics, warfarin, and steroids.

The Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug safety update in January 2010, reminding prescribers that aspirin is not licensed for primary prevention. NICE now recommends clopidogrel as a first-line treatment following an ischaemic stroke and for peripheral arterial disease. However, the situation is more complex for TIAs, with recent Royal College of Physician (RCP) guidelines supporting the use of clopidogrel, while older NICE guidelines still recommend aspirin + dipyridamole – a position the RCP state is ‘illogical’. Despite these changes, aspirin remains an important medication in the treatment of cardiovascular disease, and its use should be carefully considered based on individual patient needs and risk factors.

A pneumothorax is a condition where air accumulates in the pleural space between the parietal and visceral pleura. It can be primary or secondary, with the latter being more common in patients over 50 years old, smokers, or those with underlying lung disease. Symptoms include sudden chest pain, breathlessness, and, in severe cases, pallor, tachycardia, and hypotension. Primary spontaneous pneumothorax is more common in young adult smokers and often recurs. Secondary pneumothorax is associated with various lung diseases, including COPD and α-1-antitrypsin deficiency. A tension pneumothorax is a medical emergency that can lead to respiratory or cardiovascular compromise. Diagnosis is usually made through chest X-ray, but if a tension pneumothorax is suspected, treatment should be initiated immediately. Management varies depending on the size and type of pneumothorax, with larger pneumothoraces requiring aspiration or chest drain insertion. The safest location for chest drain insertion is the fifth intercostal space mid-axillary line within the safe triangle.

It is not recommended to exclude children from school due to head lice.

Understanding Head Lice

Head lice, also known as pediculosis capitis or ‘nits’, is a common condition in children caused by a parasitic insect called Pediculus capitis. These small insects live only on humans and feed on our blood. The eggs are glued to the hair close to the scalp and hatch in 7 to 10 days. Nits are the empty egg shells and are found further along the hair shaft as they grow out.

Head lice are spread by direct head-to-head contact and tend to be more common in children who play closely together. They cannot jump, fly, or swim. When newly infected, cases have no symptoms, but itching and scratching on the scalp occur 2 to 3 weeks after infection. There is no incubation period.

To diagnose head lice, fine-toothed combing of wet or dry hair is necessary. Treatment is only indicated if living lice are found. A choice of treatments should be offered, including malathion, wet combing, dimeticone, isopropyl myristate, and cyclomethicone. Household contacts of patients with head lice do not need to be treated unless they are also affected. School exclusion is not advised for children with head lice.

Understanding head lice is important to prevent its spread and manage the condition effectively. By knowing the symptoms, diagnosis, and management, we can take necessary precautions and seek appropriate treatment when needed.

Myth-busting HIV Treatment Guidelines

Debunking Common Misconceptions about HIV Treatment Guidelines

There are several misconceptions about HIV treatment guidelines that need to be addressed. Firstly, it is not necessary to wait until a patient’s CD4 count drops below 350 cells/ml before starting antiretroviral therapy (ART). Both the World Health Organization (WHO) and the British HIV Association (BHIVA) recommend starting treatment at any CD4 count.

Secondly, intravenous didanosine should not be used for the treatment of pregnant women. The WHO has warned against the use of didanosine and stavudine in pregnant women due to an increased risk of lactic acidosis. Women who are already taking ART and/or PCP prophylaxis before pregnancy should not discontinue their medication. If starting ART during pregnancy, potent combinations of three or more antiretroviral drugs are recommended, but this should be delayed until after the first trimester if possible.

Thirdly, HIV treatment does not involve three nucleoside analogues. Instead, treatment involves a combination of three drugs, which includes two nucleotide reverse transcriptase inhibitors (NRTIs) and one ritonavir-boosted protease inhibitor (PI/r), one non-nucleoside reverse transcriptase inhibitor (NNRTI), or one integrase inhibitor (INI).

Lastly, the use of zidovudine in post-exposure prophylaxis (PEP) for needlestick injuries in healthcare workers does not completely remove the risk of seroconversion. While this treatment option has been shown to reduce the risk, it does not eliminate it entirely.

In conclusion, it is important to stay up-to-date with current HIV treatment guidelines and to dispel any misconceptions that may exist. Starting ART at any CD4 count, avoiding certain medications during pregnancy, using a combination of three drugs, and understanding the limitations of PEP are all crucial components of effective HIV treatment.